Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia

Sponsor
Ziv Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04080973
Collaborator
(none)
150
1
1
12
12.5

Study Details

Study Description

Brief Summary

Patients suffering from acute renal colic are evaluated by non contrast computerized tomography with excellent identification rates of urinary stones. The scan also covers the bones of the ribs, spine and pelvis, allowing measurements of the bone density and identifying early osteopenic changes. Bone demineralization is associated with metabolic changes such as hypercalcemia or hypercalcuria. In this study the investigators will look for correlation between kidney stones, osteopenic bone changes and metabolic abnormalities.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CT scan
  • Diagnostic Test: 24 hour urine collection
N/A

Detailed Description

Kidney stones are a common medical condition found in more then 5% of the adult population. The stones might cause severe pain (due to acute obstruction of a renal unit) , deterioration of renal function and urinary tract infection. One of the causes of kidney stones is metabolic changes such as hypercalcemia or hyperoxaluria. Basic evaluation of kidney stones patients include measurements of calcium, phosphor and uric acid in the serum and is often negative. Thorough metabolic workup including 24 hours urine collection is not cost effective and is reserved for patients with frequent recurrence of stone disease.

Metabolic abnormalities are often associated with bone demineralization, of which the patients are typically unaware. such changes can be detected by the CT scan. On the same scan, performed for identifying the stone, the radiologist can measure bone density, using the Hounsfield units, in the L2 vertebral body of and the acetabular area of the pelvis.

In the study, in all patients undergoing CT scan due to renal colic, the bone density will be measured. Patients with abnormal bone density will undergo a complete metabolic workup including 24 hours collection of urine and measurements of urinary clearance of calcium, phosphorous, uric acid, oxalate and citrate . The investigators will look for correlation between osteopenic changes and metabolic abnormalities.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
cohort study of all patients presenting with renal coliccohort study of all patients presenting with renal colic
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Show Osteopenic Bone Changes on Non-contrast CT Scan
Anticipated Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Oct 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: osteopenic patients

patients with a kidney stone and osteopenic changes.

Diagnostic Test: CT scan
non contrast spiral CT of the urinary tract including the bony structures of the spine and pelvis

Diagnostic Test: 24 hour urine collection
24 hours collection of urine and measurement of the concentration of calcium, phosphorous, uric acid, oxalate and citrate
Other Names:
  • uninalysis
  • Outcome Measures

    Primary Outcome Measures

    1. correlation between abnormal metabolic changes and abnormal bone density on Ct scan [1 year]

      The rate of patients presenting with kidney stones and abnormal bone density and have abnormal urinary clearance of electrolytes.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years or old

    • informed consent

    • kidney stones

    • CT scan positive for stones AND bone changes

    Exclusion Criteria:
    • under 18

    • unable to sign

    • no stones detected on scan (even if a stone was expelled recently)

    • no bone changes

    • pregnancy

    • a patient already known to suffer from metabolic bone disease

    • a patient with documented osteoporosis

    • patients following spinal or pelvic trauma / surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ran Katz Safed Israel 1310000

    Sponsors and Collaborators

    • Ziv Hospital

    Investigators

    • Principal Investigator: Ran Katz, MD, Ziv Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ziv Hospital
    ClinicalTrials.gov Identifier:
    NCT04080973
    Other Study ID Numbers:
    • 0141-18-ZIV
    First Posted:
    Sep 6, 2019
    Last Update Posted:
    Sep 25, 2019
    Last Verified:
    Sep 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ziv Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 25, 2019